Fibrinolytic therapy for refractory COVID‐19 acute respiratory distress syndrome: Scientific rationale and review

The coronavirus disease 2019 (COVID‐19) pandemic has caused respiratory failure and associated mortality in numbers that have overwhelmed global health systems. Thrombotic coagulopathy is present in nearly three quarters of patients with COVID‐19 admitted to the intensive care unit, and both the cli...

Descripción completa

Detalles Bibliográficos
Autores principales: Barrett, Christopher D., Moore, Hunter B., Moore, Ernest E., McIntyre, Robert C., Moore, Peter K., Burke, John, Hua, Fei, Apgar, Joshua, Talmor, Daniel S., Sauaia, Angela, Liptzin, Deborah R., Veress, Livia A., Yaffe, Michael B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7267116/
https://www.ncbi.nlm.nih.gov/pubmed/32542213
http://dx.doi.org/10.1002/rth2.12357

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7267116/
https://www.ncbi.nlm.nih.gov/pubmed/32542213
http://dx.doi.org/10.1002/rth2.12357

Ejemplares similares